150 related articles for article (PubMed ID: 21717212)
1. Serum macrophage colony-stimulating factor (M-CSF) in patients with Hodgkin lymphoma.
Kowalska M; Tajer J; Chechlinska M; Fuksiewicz M; Kotowicz B; Kaminska J; Walewski J
Med Oncol; 2012 Sep; 29(3):2143-7. PubMed ID: 21717212
[TBL] [Abstract][Full Text] [Related]
2. Discriminant analysis involving serum cytokine levels and prediction of the response to therapy of patients with Hodgkin lymphoma.
Kowalska M; Tajer J; Chechlinska M; Fuksiewicz M; Kotowicz B; Syczewska M; Walewski J; Kaminska J
Tumour Biol; 2012 Oct; 33(5):1733-8. PubMed ID: 22678978
[TBL] [Abstract][Full Text] [Related]
3. Serum macrophage-colony stimulating factor levels in colorectal cancer patients correlate with lymph node metastasis and poor prognosis.
Mroczko B; Groblewska M; Wereszczyńska-Siemiatkowska U; Okulczyk B; Kedra B; Łaszewicz W; Dabrowski A; Szmitkowski M
Clin Chim Acta; 2007 May; 380(1-2):208-12. PubMed ID: 17368603
[TBL] [Abstract][Full Text] [Related]
4. Clinical significance of serum macrophage-colony stimulating factor (M-CSF) in esophageal cancer patients and its comparison with classical tumor markers.
Łukaszewicz-Zajac M; Mroczko B; Kozłowski M; Nikliński J; Laudański J; Szmitkowski M
Clin Chem Lab Med; 2010 Oct; 48(10):1467-73. PubMed ID: 20604722
[TBL] [Abstract][Full Text] [Related]
5. Expression of macrophage colony-stimulating factor (M-CSF) in two Hodgkin's Reed-Sternberg (H-RS) cell lines, HDLM-1 and KM-H2, and in H-RS cells in tissues.
Hsu PL; Lin YC; Hsu SM
Int J Hematol; 1991 Aug; 54(4):315-26. PubMed ID: 1838015
[TBL] [Abstract][Full Text] [Related]
6. Serum levels of granulocyte colony-stimulating factor (G-CSF) and macrophage colony-stimulating factor (M-CSF) in pancreatic cancer patients.
Groblewska M; Mroczko B; Wereszczyńska-Siemiatkowska U; Myśliwiec P; Kedra B; Szmitkowski M
Clin Chem Lab Med; 2007; 45(1):30-4. PubMed ID: 17243911
[TBL] [Abstract][Full Text] [Related]
7. Macrophage colony-stimulating factor as a tumor marker for squamous cell carcinoma of the head and neck.
Kuropkat C; Dünne AA; Plehn S; Ossendorf M; Herz U; Renz H; Werner JA
Tumour Biol; 2003; 24(5):236-40. PubMed ID: 15001836
[TBL] [Abstract][Full Text] [Related]
8. [Plasma level of macrophage-colony stimulating factor (M-CSF) in the course of breast cancer treatment].
Lawicki S; Omyła J; Mroczko B; Szmitkowski M; Czygier M
Pol Arch Med Wewn; 2004 Oct; 112(4):1181-7. PubMed ID: 15773430
[TBL] [Abstract][Full Text] [Related]
9. Serum level of macrophage colony-stimulating factor as a marker for gynecologic malignancies.
Suzuki M; Ohwada M; Sato I; Nagatomo M
Oncology; 1995; 52(2):128-33. PubMed ID: 7854772
[TBL] [Abstract][Full Text] [Related]
10. [The plasma levels of granulocyte-colony stimulating factor (G-CSF) and macrophage-colony stimulating factor (M-CSF) in breast cancer patients].
Lawicki S; Czygier M; Omyła J; Szmitkowski M
Pol Arch Med Wewn; 2006 Aug; 116(2):749-55. PubMed ID: 17424919
[TBL] [Abstract][Full Text] [Related]
11. Serum sICAM-1 (soluble intercellular adhesion molecule-1) and M-CSF (macrophage colony-stimulating growth factor) throughout monitoring of 34 non-serous ovarian cancers.
Callet N; Delaunay J; Pichon MF
Eur J Gynaecol Oncol; 2000; 21(2):135-40. PubMed ID: 10843471
[TBL] [Abstract][Full Text] [Related]
12. CSF-1R expression in tumor-associated macrophages is associated with worse prognosis in classical Hodgkin lymphoma.
Koh YW; Park C; Yoon DH; Suh C; Huh J
Am J Clin Pathol; 2014 Apr; 141(4):573-83. PubMed ID: 24619759
[TBL] [Abstract][Full Text] [Related]
13. Accumulation of T-cell clones producing high levels of both granulocyte-macrophage and macrophage colony-stimulating factors (CSF-1) in lymph nodes involved by Hodgkin's disease.
Claret E; Praloran V; Zheng X; Bonnefoix T; Sotto MF; Renversez JC; Piccinni MP; Berrada L; Sotto JJ
Leukemia; 1992 Aug; 6(8):820-7. PubMed ID: 1640735
[TBL] [Abstract][Full Text] [Related]
14. Hematopoietic growth factors in colorectal cancer patients.
Mroczko B; Szmitkowski M; Okulczyk B
Clin Chem Lab Med; 2003 May; 41(5):646-51. PubMed ID: 12812262
[TBL] [Abstract][Full Text] [Related]
15. Granulocyte-Colony stimulating factor and macrophage-colony stimulating factor in patients with non-small-cell lung cancer.
Mroczko B; Szmitkowski M; Niklinski J
Clin Chem Lab Med; 2001 May; 39(5):374-9. PubMed ID: 11434384
[TBL] [Abstract][Full Text] [Related]
16. Granulocyte colony stimulating factor (G-CSF) and macrophage colony stimulating factor (M-CSF) as potential tumor markers in non small cell lung cancer diagnosis.
Bahar B; Acedil Ayc Iota B; Çoşkun U; Büyükberber S; Benekli M; Yildiz R
Asian Pac J Cancer Prev; 2010; 11(3):709-12. PubMed ID: 21039040
[TBL] [Abstract][Full Text] [Related]
17. Galectin-1 serum levels reflect tumor burden and adverse clinical features in classical Hodgkin lymphoma.
Ouyang J; Plütschow A; Pogge von Strandmann E; Reiners KS; Ponader S; Rabinovich GA; Neuberg D; Engert A; Shipp MA
Blood; 2013 Apr; 121(17):3431-3. PubMed ID: 23444403
[TBL] [Abstract][Full Text] [Related]
18. Prognostic value of some inflammatory markers in patients with lymphoma.
Hamed Anber N; El-Sebaie AH; Darwish NHE; Mousa SA; Shamaa SS
Biosci Rep; 2019 Mar; 39(3):. PubMed ID: 30814315
[No Abstract] [Full Text] [Related]
19. Expression of membrane-associated macrophage colony-stimulating factor (M-CSF) in Hodgkin's disease and other hematologic malignancies.
Zheng GG; Wu KF; Geng YQ; Kong J; Al-Katib A; Dan M; Chen B
Leuk Lymphoma; 1999 Jan; 32(3-4):339-44. PubMed ID: 10037031
[TBL] [Abstract][Full Text] [Related]
20. Phase II study of immunomodulation with granulocyte-macrophage colony-stimulating factor, interleukin-2, and rituximab following autologous stem cell transplant in patients with relapsed or refractory lymphomas.
Poiré X; Kline J; Grinblatt D; Zimmerman T; Conner K; Muhs C; Gajewski T; Van Besien K; Smith SM
Leuk Lymphoma; 2010 Jul; 51(7):1241-50. PubMed ID: 20496994
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
